{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:15:52Z","timestamp":1795029352986,"version":"4.10.2"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40918"],"award-info":[{"award-number":["2023JJ40918"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ3052"],"award-info":[{"award-number":["2024JJ3052"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012176","name":"Project 211","doi-asserted-by":"publisher","award":["B20017"],"award-info":[{"award-number":["B20017"]}],"id":[{"id":"10.13039\/501100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82221002"],"award-info":[{"award-number":["82221002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203024"],"award-info":[{"award-number":["82203024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073458"],"award-info":[{"award-number":["82073458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biomaterials.2024.122815","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T12:22:29Z","timestamp":1726057349000},"page":"122815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1\/CCL5 mediated M1 macrophage polarization in melanoma"],"prefix":"10.1016","volume":"314","author":[{"given":"Nian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-5490","authenticated-orcid":false,"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7637","key":"10.1016\/j.biomaterials.2024.122815_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122815_bib2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122815_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002309","article-title":"Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis","volume":"14","author":"Snyder","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.biomaterials.2024.122815_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ctrv.2016.11.007","article-title":"Resistance to PD1\/PDL1 checkpoint inhibition","volume":"52","author":"O'Donnell","year":"2017","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/2326-6066.CIR-18-0272","article-title":"Intracellular activation of complement C3 leads to PD-L1 antibody treatment resistance by modulating tumor-associated macrophages","volume":"7","author":"Zha","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"7629","key":"10.1016\/j.biomaterials.2024.122815_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3Kgamma is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122815_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41389-018-0049-3","article-title":"Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression","volume":"7","author":"Wang","year":"2018","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"issue":"10240","key":"10.1016\/j.biomaterials.2024.122815_bib11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(20)30934-X","article-title":"Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF(V600) mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial","volume":"395","author":"Gutzmer","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122815_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41591-019-0535-y","article-title":"Publisher Correction: combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","volume":"25","author":"Ribas","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122815_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.tips.2016.06.010","article-title":"Potential reuse of oncology drugs in the treatment of rare diseases","volume":"37","author":"Liu","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2024.122815_bib14","article-title":"Immunotherapy and prevention of cancer by nanovaccines loaded with whole-cell components of tumor tissues or cells","author":"Ma","year":"2021","journal-title":"Adv Mater"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122815_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/M17-3085","article-title":"Use of low-dose aspirin and mortality after prostate cancer diagnosis: a nationwide cohort study","volume":"170","author":"Skriver","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122815_bib16","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jamaoncol.2018.4149","article-title":"Association of analgesic use with risk of ovarian cancer in the nurses' health studies","volume":"4","author":"Barnard","year":"2018","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122815_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/cid\/ciy1029","article-title":"IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections","volume":"69","author":"Solomkin","year":"2019","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"issue":"23","key":"10.1016\/j.biomaterials.2024.122815_bib18","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1158\/0008-5472.CAN-06-1536","article-title":"A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122815_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007146","article-title":"Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis","volume":"11","author":"Liu","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41419-023-05692-5","article-title":"Supplementation with \u03b1-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tibs.2010.07.007","article-title":"Regulation of autophagy by ROS: physiology and pathology","volume":"36","author":"Scherz-Shouval","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122815_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10571-015-0166-x","article-title":"ROS and autophagy: interactions and molecular regulatory mechanisms","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122815_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41423-019-0279-0","article-title":"CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization","volume":"17","author":"Li","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122815_bib24","article-title":"Reprogramming macrophage polarization, depleting ROS by astaxanthin and thioketal-containing polymers delivering rapamycin for osteoarthritis treatment","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122815_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","article-title":"Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-\u03baB\/MAPK signaling and protecting chondrocytes","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2019.03.014","article-title":"Macrophage p38\u03b1 promotes nutritional steatohepatitis through M1 polarization","volume":"71","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"issue":"6371","key":"10.1016\/j.biomaterials.2024.122815_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122815_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/phar.2167","article-title":"FDA breakthrough therapy designation: evaluating the quality of the evidence behind the drug approvals","volume":"38","author":"Herink","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122815_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","article-title":"Drug repurposing for rare diseases","volume":"42","author":"Roessler","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122815_bib32","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/jcb.27646","article-title":"Macrophage polarity in cancer: a review","volume":"120","author":"Najafi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"40","key":"10.1016\/j.biomaterials.2024.122815_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2021.11.012","article-title":"Multiomic profiling of checkpoint inhibitor-treated melanoma: identifying predictors of response and resistance, and markers of biological discordance","volume":"40","author":"Newell","year":"2022","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.biomaterials.2024.122815_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151347","article-title":"Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma","volume":"131","author":"Chakraborty","year":"2021","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122815_bib37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10753-013-9621-3","article-title":"The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4R\u03b1) signaling","volume":"36","author":"Ferrante","year":"2013","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122815_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7047","key":"10.1016\/j.biomaterials.2024.122815_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature03688","article-title":"Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability","volume":"436","author":"Radisky","year":"2005","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.biomaterials.2024.122815_bib40","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","volume":"119","author":"Nieborowska-Skorska","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2024.122815_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122815_bib42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122815_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12272-017-0990-2","article-title":"Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway","volume":"41","author":"Cui","year":"2018","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122815_bib44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122815_bib45","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","article-title":"Emerging mechanisms and targeted therapy of ferroptosis in cancer","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122815_bib46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122815_bib48","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4103\/1673-5374.135329","article-title":"Autophagy: a double-edged sword for neuronal survival after cerebral ischemia","volume":"9","author":"Chen","year":"2014","journal-title":"Neural regeneration research"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122815_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/cvr\/cvt035","article-title":"Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma?","volume":"98","author":"Chen","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122815_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41418-018-0252-y","article-title":"Autophagy-dependent cell death","volume":"26","author":"Denton","year":"2019","journal-title":"Cell Death Differ."},{"issue":"6062","key":"10.1016\/j.biomaterials.2024.122815_bib51","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2024.122815_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109746","article-title":"Synergic effect of PD-1 blockade and endostar on the PI3K\/AKT\/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model","volume":"125","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7806","key":"10.1016\/j.biomaterials.2024.122815_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122815_bib55","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s43018-022-00448-0","article-title":"Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity","volume":"3","author":"Tian","year":"2022","journal-title":"Nature cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122815_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 Axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122815_bib57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","article-title":"Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Death Differ."},{"issue":"13","key":"10.1016\/j.biomaterials.2024.122815_bib58","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.7150\/ijbs.74647","article-title":"Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122815_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122815_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02201-4","article-title":"Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPAR\u03b1-CYP4X1 axis in colonic macrophages","volume":"41","author":"Chen","year":"2022","journal-title":"Journal of experimental & clinical cancer research : CR"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122815_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microb."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122815_bib62","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"issue":"6575","key":"10.1016\/j.biomaterials.2024.122815_bib63","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122815_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","article-title":"Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1","volume":"28","author":"McCulloch","year":"2022","journal-title":"Nat Med"},{"issue":"6371","key":"10.1016\/j.biomaterials.2024.122815_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:06:28Z","timestamp":1777485988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"alternative-id":["S0142961224003491"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122815","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1\/CCL5 mediated M1 macrophage polarization in melanoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122815"}}